March 28, 2022 07:20 AM EDT
Pharma

Ver­tex strikes agree­ment with Aus­tralia for cys­tic fi­bro­sis pill, end­ing high-pro­file stand­off

Jason Mast

Editor

Ver­tex reached an agree­ment on Sun­day to sell its newest cys­tic fi­bro­sis drug in Aus­tralia, end­ing a high-pro­file stand­off over ac­cess to a life-al­ter­ing but …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Dai­ichi Sankyo finds suc­ces­sor to late R&D ex­ec; Ver­sant, No­var­tis' kid­ney biotech poach­es Sana CBO

A service from the Financial Times